1. Home
  2. KINS vs EMBC Comparison

KINS vs EMBC Comparison

Compare KINS & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KINS

Kingstone Companies Inc.

SELL

Current Price

$18.72

Market Cap

284.5M

Sector

Finance

ML Signal

SELL

Logo Embecta Corp.

EMBC

Embecta Corp.

SELL

Current Price

$6.32

Market Cap

328.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
KINS
EMBC
Founded
1886
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
284.5M
328.1M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
KINS
EMBC
Price
$18.72
$6.32
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
57.4K
★ 837.1K
Earning Date
11-05-2026
11-24-2026
Dividend Yield
★ 1.28%
0.64%
EPS Growth
★ 94.59
20.90
EPS
0.66
★ 1.03
Revenue
★ $214,867,301.00
N/A
Revenue This Year
$18.83
N/A
Revenue Next Year
$15.85
$5.59
P/E Ratio
$28.27
★ $6.10
Revenue Growth
★ 38.50
N/A
52 Week Low
$13.83
$2.77
52 Week High
$20.90
$14.91

Technical Indicators

Market Signals
Indicator
KINS
EMBC
Relative Strength Index (RSI) 49.95 66.56
Support Level $18.68 $3.01
Resistance Level $19.31 $9.38
Average True Range (ATR) 0.46 0.28
MACD 0.07 0.03
Stochastic Oscillator 75.41 77.52

Price Performance

Historical Comparison
KINS
EMBC

About KINS Kingstone Companies Inc.

Kingstone Companies Inc offers property and casualty insurance products through its subsidiary engaged in writing business through retail and wholesale agents and brokers. Its products include Personal lines, Livery physical damage, and Others. It operates in single segment, property and casualty insurance. It derives substantially all of its revenue from KICO, including revenues from earned premiums, ceding commissions from quota share reinsurance, net investment income generated from its investment portfolio, and net realized gains and losses on investment securities.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: